Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Communication Skills Intervention to Promote Transition Into Survivorship
This clinical trial update describes a communication skills intervention intended to help patients with Hodgkin lymphoma and diffuse large B…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors [NA]
A clinical trial update describing a study on implementing lifestyle-based survivorship care plans for lymphoma survivors.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial at Mayo Clinic evaluating low-dose selinexor in combination with choline salicylate for relapsed or refractory Hodgkin lymph…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]
Phase 1 study of CAR-T cells targeting CD30 and CCR4 for relapsed/refractory CD30+ Hodgkin lymphoma and cutaneous T-cell lymphoma, with the …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL [Phase 1, Phase 2]
Update on a CD30-targeted CAR-T cell therapy being studied for relapsed/refractory Hodgkin lymphoma and CD30+ Non-Hodgkin lymphoma in Phase …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
A clinical trial update focusing on diagnosing PAX5-negative Hodgkin-like lymphomas, highlighting the diagnostic challenges in Hodgkin and n…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma [NA]
This clinical trial update describes a study evaluating clearance of minimal residual disease at the end of first-line treatment in patients…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma [NA]
An ongoing radiation dose study for relapsed/refractory Hodgkin lymphoma and non-Hodgkin lymphoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A Stanford University–sponsored clinical trial is recruiting to study clinical and pathologic aspects of Non-Hodgkin lymphoma and Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus–associated lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma [Phase 3]
This clinical trial update describes an ongoing Phase 3 study evaluating PET-guided dose reduction for involved-site radiotherapy in early-s…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: STAY-STRONG Study of Exercise Training During Chemotherapy [NA]
The STAY-STRONG study evaluating exercise training during chemotherapy in lymphoma patients has completed, examining effects on body composi…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy [Phase 2]
This clinical trial update describes a Phase 2 study evaluating frontline tislelizumab in patients with de novo Hodgkin lymphoma who are uns…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.
This clinical trial investigates genetic markers that predict susceptibility to chemotherapy-induced ovarian damage in cancer patients under…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial assessing a Yttrium-90 labeled anti-CD25 monoclonal antibody plus BEAM chemotherapy conditioning for patients with …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]
A Phase 1 trial evaluating the combination of duvelisib with BMS-986345 in lymphoid malignancies, including non-Hodgkin lymphoma and Hodgkin…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multip…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Nivo40-AVD for Advanced Classic Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating nivolumab plus AVD (Nivo40-AVD) in adults with advanced classic Hodgkin lymphoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and axatilimab in relapsed or refractory classical Hodgkin lymphoma, currently recru…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)
This clinical trial update reports real-world efficacy and toxicity data for the combination of Brentuximab vedotin with Bendamustine in pat…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]
A Phase 1 trial evaluating natural killer cell therapy in combination with Interleukin-2 and the TGF-beta receptor I inhibitor vactosertib f…